VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, In vivo effect on angiogenesis and endogenous protein expression

J Woolard, W Wang, HS Bevan, Y Qiu, L Morbidelli, RO Pritchard-Jones, T-G Cui, M Sugiono, EC Waine, RM Perrin, RR Foster, J Digby-Bell, JD Shields, CE Whittles, RE Mushens, D Gillatt, M Ziche, SJ Harper, DO Bates

Research output: Contribution to journalArticle (Academic Journal)

352 Citations (Scopus)
Original languageEnglish
Pages (from-to)7822 - 7835
Number of pages14
JournalCancer Research
Volume64 (21)
DOIs
Publication statusPublished - Nov 2004

Bibliographical note

Publisher: American Association for Cancer Research

Cite this

Woolard, J., Wang, W., Bevan, HS., Qiu, Y., Morbidelli, L., Pritchard-Jones, RO., Cui, T-G., Sugiono, M., Waine, EC., Perrin, RM., Foster, RR., Digby-Bell, J., Shields, JD., Whittles, CE., Mushens, RE., Gillatt, D., Ziche, M., Harper, SJ., & Bates, DO. (2004). VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, In vivo effect on angiogenesis and endogenous protein expression. Cancer Research, 64 (21), 7822 - 7835. https://doi.org/10.1158/0008-5472.CAN-04-0934